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Abstract.	
	
The	objective	of	the	research	was	to	determine	the	features	of	the	blood	
coagulation	 system	 in	 patients	 at	 high	 and	 very	 high	 cardiovascular	 risk	
according	to	the	SCORE	charts	in	the	presence	of	heart	rate	turbulence.	
	 Materials	 and	methods.	 	 603	patients	were	 examined	 to	determine	 the	
role	of	heart	rate	variability	in	the	cardiovascular	continuum;	319	patients	were	
examined	 to	 study	 the	 role	 of	 heart	 rate	 turbulence	 in	 the	 formation	 and	
progression	 of	 sudden	 death	 in	 the	 cardiovascular	 continuum	 based	 on	 the	
Holter	 monitoring.	 All	 patients	 were	 divided	 into	 4	 groups:	 Group	 1	 included	
patients	with	coronary	heart	disease	without	concomitant	 risk	 factors	such	as	
smoking,	obesity,	metabolic	 syndrome;	Group	2	 consisted	of	patients	 smoking	
tobacco	 for	 more	 than	 2	 years;	 Group	 3	 included	 patients	 with	 metabolic	
syndrome	 without	 existing	 coronary	 heart	 disease	 or	 arterial	 hypertension;	
Group	 4	 consisted	 of	 patients	 with	 metabolic	 syndrome	 and	 arterial	
hypertension.	 The	 control	 group	 included	 149	 people.	 In	 patients	 with	
ventricular	 extrasystoles	 of	 different	 degrees	 according	 to	 V.	 Lown’s	 and	 M.	
Wolf’s	scale	 the	 phenomenon	 of	 heart	 rate	 turbulence	 was	 observed	 and	 the	
parameters	of	the	blood	coagulation	system	were	determined.	
	 Results.	 There	 was	 no	 significant	 difference	 between	 indices	 of	
coagulation	among	studied	groups	and	the	control	group.	In	patients	with	post-
infarction	 cardiosclerosis	 hematocrit	 was	 lower	 due	 to	 regular	 intake	 of	
antiplatelet	drugs	to	prevent	the	progression	of	coronary	heart	disease.	It	can	be	
stated	 that	 the	phenomenon	of	heart	 rate	 turbulence	 itself	does	not	affect	 the	
change	 in	 the	 coagulation	 system	 of	 the	 human	 body.	When	 determining	 the	
advisability	 of	 administering	 anticoagulants	 to	 patients	 with	 heart	 rate	
turbulence,	we	should	be	guided	by	not	only	the	presence	of	ventricular	ectopy	
the	total	cardiovascular	risk	should	be	considered	as	well.	
	 Conclusions.	The	presence	of	isolated	heart	rate	turbulence	
phenomenon	in	a	patient	does	not	require	a	special	approach	to	anticoagulant	
therapy.	
 Copyright	©	Author(s),	2016	
	
Archive	of	Clinical	Medicine,	Vol.	22,	No.	1	(2016)	 ISSN	2414-9853	
	
	
Journal	homepage:	http://ojs.ifnmu.edu.ua/index.php/acm  
67	
Problem	statement	and	analysis	of	the	recent	research	
	 The	fight	against	sudden	death	is	one	of	the	most	important	problems	of	the	modern	health	
care.	This	problem	 is	of	great	 importance	due	 to	 losses	 to	 the	 society	 [1].	The	main	difficulty	 in	
fighting	against	sudden	cardiac	death	is	to	save	the	patients	with	sudden	cardiac	death;	in	the	USA	
this	indicator	is	about	5%,	while	around	the	world	it	is	less	than	1%	[4].	There	are	a	lot	of	reasons	
for	these	failures.	The	main	among	them	is	the	fact	that	the	aid	(resuscitation)	should	be	provided	
in	a	 few	minutes,	as	a	 further	effect	of	 treatment	 reduces.	 It	 should	be	noted	 that	about	80%	of	
sudden	cardiac	death	occur	in	the	absence	of	the	bystanders,	and	if	they	are	present,	they	usually	
do	not	have	the	necessary	tools	or	resuscitation	skills.	Due	to	this,	the	problem	of	predicting	sudden	
cardiac	death	is	of	primary	importance	[2].	There	are	primary	and	secondary	prevention	of	sudden	
cardiac	 death.	 The	 latter	 is	 performed	 in	 patients	 who	 were	 saved	 from	 sudden	 cardiac	 death.	
Primary	 prevention	 is	 a	 series	 of	 therapeutic	 measures	 in	 patients	 at	 increased	 risk	 of	 sudden	
cardiac	death	[5].	Considering	all	the	mentioned	above,	it	is	clear	that	the	main	way	to	reduce	losses	
from	sudden	cardiac	death	 is	 the	primary	prevention.	The	existing	selection	criteria	 for	primary	
prevention	of	sudden	cardiac	death	are	not	sufficiently	effective	 [3].	 In	 this	regard,	an	 important	
task	is	to	improve	the	existing	criteria	for	primary	prevention	of	sudden	cardiac	death	as	well	as	to	
search	 for	new	ones;	 to	separate	patients	at	 increased	 risk	of	sudden	cardiac	death.	 It	should	be	
noted,	 that	 most	 of	 them	 are	 those	 with	 structural	 heart	 diseases;	 80%	 of	 patients	 suffer	 from	
coronary	 heart	 disease	 and	 hypertension,	 15%	 of	 patients	 are	 diagnosed	 with	 non-ischemic	
cardiomyopathy	and	only	5%	of	patients	do	not	have	any	structural	heart	disease	[6,	7].	Thrombosis	
is	 one	 of	 the	 most	 severe	 complications	 of	 heart	 disease	 and	 its	 consequences	 are	 difficult	 to	
predict:	it	can	result	in	the	embolization	of	cerebral	vessels	with	further	development	of	ischemic	
stroke	 as	 well	 as	 in	 the	 embolization	 of	 the	 coronary	 artery	 with	 further	 development	 of	 acute	
coronary	syndrome,	or	embolization	of	the	pulmonary	arterial	branches.	Each	of	these	effects	can	
lead	 to	 disability	 as	 well	 as	 to	 mortality.	 Therefore,	 the	 prevention	 of	 thrombosis	 ranks	 first	 in	
treatment	of	patients	with	diseases	of	the	cardiovascular	system.	If	in	ischemic	heart	disease	white	
blood	clots	occur	in	patients	with	impaired	heart	rate	the	focus	should	be	on	the	antiplatelet	drugs;	
if	there	are	red	blood	clots	treatment	should	be	focused	on	anticoagulant	therapy.	The	prevention	
and	 treatment	 of	 coronary	 heart	 disease	 is	 described	 in	 many	 research	 works.	 If	 a	 patient	 is	
diagnosed	with	coronary	heart	disease	the	mandatory	component	in	his/her	treatment	should	be	
antiplatelet	 drug	 aspirin,	 and	 in	 case	 of	 intolerance,	 it	 may	 be	 clopidogrel.	 In	 case	 of	 atrial	
fibrillation	 or	 atrial	 flutter	 the	 usage	 of	 warfarin	 is	 recommended.	 In	 the	 last	 2-3	 years	 new	
anticoagulants	debihatran	and	 rivaroxaban	appeared	 to	 replace	warfarin.	However,	 the	question	
of	the	prevention	of	thrombosis	in	cardiac	rhythm	disorder	(ventricular	arrhythmia)	remains	to	be	
insufficiently	described	in	literature.	
	 The	objective	of	our	research	was	to	determine	the	features	of	the	parameters	of	the	blood	
coagulation	system	 in	patients	at	high	and	very	high	cardiovascular	risk	according	 to	 the	SCORE	
charts	and	past	myocardial	infarction	in	the	presence	of	heart	rate	turbulence.	
	 	
Materials	and	methods	
	 4214	patients	at	the	age	of	35-85	years	were	examined	during	the	period	2007-2013.	In	921	
patients	 the	 phenomenon	 of	 heart	 rate	 turbulence	 was	 found.	 319	 patients	 (198	 men	 and	 121	
women)	were	examined	to	study	the	role	of	heart	rate	turbulence	in	the	formation	and	progression	
of	sudden	death	in	the	cardiovascular	continuum.	The	predominance	of	men	can	be	explained	by	
the	fact	that	due	to	moral	and	religious	features	of	our	country,	men	are	more	likely	to	smoke	than	
women.	It	should	be	noted	that	the	relative	number	of	female	patients	with	coronary	heart	disease	
until	 they	 reach	 menopause	 is	 less	 than	 that	 in	 men	 of	 their	 age	 category.	 The	 study	 excluded	
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patients	 with	 concomitant	 myocardial	 injury	 (acute	 coronary	 syndrome	 with	 the	 presence	 or	
absence	of	ST	segment	elevation,	secondary	arterial	hypertension,	permanent	atrial	fibrillation	or	
atrial	flutter),	autoimmune,	hematological	diseases,	mental	disorders,	endocrine	disorders	(except	
for	patients	with	diabetes	mellitus),	acute	renal	and	hepatic	failure,	cancer,	pregnant	women,	and	
athletes.	 All	 patients	 underwent	 inpatient	 treatment	 or	 were	 referred	 by	 regional	 hospitals	 to	
consult	a	cardiologist	in	the	Ivano-Frankivsk	Regional	Clinical	Cardiology	Dispensary.	All	patients	
were	divided	into	4	groups.	Group	1	included	patients	with	coronary	heart	disease	(post-infarction	
cardiosclerosis)	without	concomitant	risk	 factors	such	as	smoking,	obesity,	metabolic	syndrome.	
This	group	consisted	of	163	persons	with	the	phenomenon	of	heart	rate	turbulence	(102	males	and	
61	 females).	 Group	 2	 included	 patients	 at	 very	 high	 cardiovascular	 risk	 according	 to	 the	 SCORE	
charts.	This	group	consisted	of	85	people	with	ventricular	arrhythmia	without	the	phenomenon	of	
heart	rate	turbulence	(82	men	and	3	women).	Group	3	included	patients	at	high	cardiovascular	risk	
according	to	the	SCORE	charts.	 In	this	group	there	were	118	people	 (63	men	and	55	women).	The	
control	group	consisted	of	50	(25	men	and	25	women)	practically	healthy	persons.	When	examining	
the	control	group	using	the	Holter	monitoring	ventricular	extrasystole	was	detected	in	all	patients,	
however,	 the	number	 of	 extrasystoles	did	not	 exceed	normal	 values.	One	 of	 the	 criteria	 for	 the	
development	of	sudden	cardiac	death	is	increased	blood	clotting	and	thrombosis.	The	presence	of	
ectopic	 heartbeat	 itself	 increases	 the	 risk	 of	 thrombosis.	 To	 identify	 the	 risk	 of	 thrombosis	 in	
patients	 with	 the	 phenomenon	 of	 heart	 rate	 turbulence	 the	 analysis	 of	 coagulation	 profile	
parameters	was	made:	 the	prothrombin	 time	and	 index,	 the	 international	normalized	 ratio	and	
activated	recalcification	time,	fibrinogen	level,	hematocrit,	and	thrombotest.	
	 	
Results	
	 The	parameters	of	the	blood	coagulation	system	of	studied	groups	are	presented	in	Table	1.		
	
Table	1	
Features	of	coagulation	profile	parameters	in	patients	of	studied	groups	with	the	phenomenon	of	
heart	rate	turbulence	
	 Prothrombin	
index	(time),		
%	
Normalized	
international	
ratio	
Activated	time	
of	
recalcification,	
seconds	
Fibrinogen,			
g	
Hematocrit,	
%	
Trombotest,	
degree	
Group	
1	
91.81±3.16	
16.93±0.71	
2.33±0.14	 92.78±3.75	 2.47±0.15	 37±1.98	1	 4.16±1.15	
Group	
2	
88.43±2.58	
(17.27±0.55)	
2.87±0.23	 107.93±9.09	 2.78±0.21	 49.33±1.81	 5±0.36	
Group	
3	
94.56±6.47	
16.03±1.19	
2.46±0.26	 94.00±6.11	 2.97±0.29	 50±0.31	 5±0.71	
Group	
4	
97.43±2.58	
(20.55±0.55)	
2.09±0.25	 90.97±9.09	 2.85±0.21	 45.53±1.81	 5.3±0.36	
Control	
group	
90.07±2.94	
17.12±0.39	
2.59±0.33	 91.09±3.08	 2.82±0.23	 49.0±2.82	 5±0.37	
Note:		
1-	difference	between	the	control	group	and	studied	group	p<0.01	
	 	
When	analyzing	and	comparing	the	parameters	of	coagulation	profile	in	patients	with	past	
myocardial	infarction	and	in	healthy	persons	it	was	found	that	there	was	no	significant	differences	
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in	the	prothrombin	time	and	index,	the	international	normalized	ratio	and	activated	recalcification	
time,	 fibrinogen	 level	 and	 thrombotest	 values.	 	 In	 patients	 with	 post-infarction	 cardiosclerosis	
hematocrit	was	significantly	 lower	 (p<0.01)	due	 to	 regular	 intake	of	antiplatelet	drugs	 to	prevent	
the	 progression	 and	 complications	 of	 coronary	 heart	 disease.	 In	 people	 of	 Group	 1	 trombotest	
values	were	 lower	 than	 in	 the	control	group	-	4.16	+	1.15	vs.	0.37	+	5.0.37.	The	 level	of	 fibrinogen	
was	also	lower	in	patients	of	Group	1	-	2.47	+	0.15	vs.	2.82	+	0.23.	There	was	no	significant	difference	
in	 the	 parameters	 of	 coagulation	 profile	 between	 patients	 of	 Group	 2	 and	 the	 control	 group.	 In	
patients	at	very	high	cardiovascular	risk	activated	recalcification	time	was	 longer	than	that	 in	all	
studied	groups.	In	patients	of	Group	3	there	was	no	significant	difference	between	the	parameters	
of	 coagulation	profile.	The	prothrombin	 time	and	 index,	 trombotest	values	were	 slightly	higher;	
activated	recalcification	time,	fibrinogen	level	and	hematocrit	were	slightly	lower.	
	 	
Discussion	
	 There	 was	 no	 significant	 difference	 in	 the	 parameters	 of	 coagulation	 profile	 between	
studied	 groups	 and	 the	 control	 group;	 only	 in	 patients	 with	 post-infarction	 cardiosclerosis	
hematocrit	 was	 lower	 due	 to	 regular	 intake	 of	 antiplatelet	 drugs	 to	 prevent	 the	 progression	 of	
coronary	heart	disease.	It	can	be	stated	that	the	phenomenon	of	heart	rate	turbulence	 itself	does	
not	 affect	 the	 change	 in	 the	 coagulation	 system	 of	 the	 human	 body.	 When	 determining	 the	
advisability	of	administering	anticoagulants	to	patients	with	heart	rate	turbulence,	we	should	be	
guided	 by	 not	 only	 the	 presence	 of	 ventricular	 ectopy	 the	 total	 cardiovascular	 risk	 should	 be	
considered	as	well.	
	 	
Conclusions	
	 The	presence	of	 isolated	heart	rate	 turbulence	phenomenon	 in	a	patient	does	not	require	
any	special	approach	to	anticoagulant	therapy.	
	 	
Prospects	for	further	research	
	 In	this	regard,	an	important	task	is	to	improve	the	existing	criteria	for	primary	prevention	
of	sudden	cardiac	death	as	well	as	to	search	for	new	ones;	to	separate	patients	at	increased	risk	of	
sudden	cardiac	death.	The	determination	of	the	heart	rate	variability	and	heart	rate	turbulence	can	
be	quite	simple	non-invasive	and	available	screening	method	for	early	detection	of	patients	with	a	
predisposition	to	sudden	cardiac	death.	
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